Get With the Guidelines Atrial Fibrillation Registry

Last updated: January 27, 2025
Sponsor: American Heart Association
Overall Status: Active - Recruiting

Phase

N/A

Condition

Atrial Fibrillation

Chest Pain

Atrial Flutter

Treatment

GWTG Atrial Fibrillation program

Clinical Study ID

NCT06245187
002
  • Ages 18-125
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter

Exclusion

Exclusion Criteria:

  • Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter

  • Patients under 18 years of age

  • Patients not admitted as inpatients.

  • Patients on comfort care only

  • Patients discharged to hospice.

Study Design

Total Participants: 17198
Treatment Group(s): 1
Primary Treatment: GWTG Atrial Fibrillation program
Phase:
Study Start date:
January 01, 2013
Estimated Completion Date:
January 31, 2040

Study Description

Get With The Guidelines-Atrial Fibrillation was initiated in 2013 with over 88 U.S. hospitals participating is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Achievement measures tracked through Get With The Guidelines-Atrial Fibrillation:

  1. ACEI/ARB at discharge for LVSD

  2. Assessment of thromboembolic risk factors

  3. Beta Blocker at discharge

  4. Discharged on FDA-approved anticoagulation therapy

  5. PT/INR planned follow-up

  6. Statin at discharge in AF patients with CAD, CVA/TIA or PVD.

Quality measures tracked through Get With The Guidelines-Atrial Fibrillation:

  1. Aldosterone antagonist at discharge

  2. Atrial fibrillation patient education

  3. Anticoagulation therapy education

  4. CHA2DS2-VASC reported

  5. Discharge heart rate <110bpm

  6. Smoking cessation

  7. Warfarin at discharge for valvular atrial fibrillation

Additional measures collected by Get With The Guidelines-Atrial Fibrillation can be viewed at: http://www.heart.org/idc/groups/heart-public/@private/@wcm/@hcm/@gwtg/documents/downloada ble/ucm_451183.pdf

Connect with a study center

  • Amy Bennett

    Dallas, Texas 75231
    United States

    Active - Recruiting

  • Kelly Burlison

    Dallas, Texas 75231
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.